文献速递治疗药物监测与药物基因组学抗栓抗凝管理

阿拉巴马大学伯明翰分校精准医学:通过实施基因型指导的抗血小板治疗奠定基础流程

Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet Therapy.
PubMed 文献 · Clin Pharmacol Ther · 2017-06-01

本文介绍阿拉巴马大学伯明翰分校(UAB)在精准医学领域的努力,重点是通过实施基因型指导的抗血小板治疗来奠定基础流程。文章指出药物基因组学(PGx)是精准医学的重要组成部分,但基因型指导药物治疗(GGTx)的临床整合面临证据识别、医生培训、临床决策支持(CDS)和报销等挑战。UAB的举措旨在应对这些挑战并改善 racially diverse 患者的健康。

要点

  • 药物基因组学是精准医学的重要组成,基因型指导药物治疗整合面临多重挑战。
  • UAB通过实施基因型指导的抗血小板治疗建立精准医学基础流程。
  • 挑战包括证据强度、医生培训、临床决策支持和报销限制。

核心结论

  • UAB的精准医学举措旨在应对基因型指导药物治疗整合中的挑战,并改善不同种族患者的健康。

研究设计与样本

  • 本文为描述UAB精准医学实施经验的文章,未报告具体研究设计与样本量。

主要发现

  • 过去十年研究已识别影响药物反应的基因和单核苷酸多态性(SNPs)并量化其效应。
  • 即时检测(POC)基因分型平台的发展使得在诊疗时间窗内检测基因/SNPs成为可能。
  • 基因型指导药物治疗(GGTx)的实践整合仍面临显著挑战。

临床怎么用

  • 通过实施基因型指导的抗血小板治疗,建立精准医学的基础流程。

局限性

  • 识别具有足够稳健证据以指导临床决策的SNPs存在困难。
  • 缺乏关于如何开具和利用基因型数据的临床医生培训。
  • 缺乏指导治疗的临床决策支持(CDS)。
  • 报销有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Precision medicine entails tailoring treatment based on patients' unique characteristics. As drug therapy constitutes the cornerstone of treatment for most chronic diseases, pharmacogenomics (PGx), the study of genetic variation influencing individual response to drugs, is an important component of precision medicine. Over the past decade investigations have identified genes and single-nucleotide polymorphisms (SNPs) and quantified their effect on drug response. Parallel development of point-of-care (POC) genotyping platforms has enabled the interrogation of the genes/SNPs within a timeline conducive to the provision of care. Despite these advances, the pace of integration of genotype-guided drug therapy (GGTx) into practice has faced significant challenges. These include difficulty in identifying SNPs with sufficiently robust evidence to guide clinical decision making, lack of clinician training on how to order and use genotype data, lack of clinical decision support (CDS) to guide treatment, and limited reimbursement. The University of Alabama at Birmingham's (UAB) efforts in precision medicine were initiated to address these challenges and improve the health of the racially diverse patients we treat.

来源:Clin Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Harada S, Zhou Y, Duncan S, et al. Precision Medicine at the University of Alabama at Birmingham: Laying the Foundational Processes Through Implementation of Genotype-Guided Antiplatelet Therapy. Clin Pharmacol Ther. 2017. PMID: 28124392. doi:10.1002/cpt.631

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。